Anti-Müllerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.

Conclusions: The decrease of AMH levels in PCOS women after one week of ovarian stimulation is a practical, valuable indicator which could predict the patients with a high risk of ovarian hyperstimulation. Anovulating PCOS patients with severe hyperandrogenism, insulin resistance and hyperinsulinaemia should not be qualified for recFSH ovarian stimulation. (Endokrynol Pol 2013; 64 (3): 203-207). PMID: 23873424 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23873424?dopt=Abstract

Source: Endokrynologia Polska - July 24, 2013 Category: Endocrinology Authors: Dąbkowska-Huć A, Lemm M, Sikora J, Witek A, Skałba P Tags: Endokrynol Pol Source Type: research